Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032707
Filing Date
2024-08-16
Accepted
2024-08-15 18:31:59
Documents
42
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 576258
2 ex31-1.htm EX-31.1 16595
3 ex31-2.htm EX-31.2 16772
4 ex32-1.htm EX-32.1 8381
5 logo.jpg GRAPHIC 5203
  Complete submission text file 0001493152-24-032707.txt   2535596

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cqens-20240630.xsd EX-101.SCH 18595
7 XBRL CALCULATION FILE cqens-20240630_cal.xml EX-101.CAL 35219
8 XBRL DEFINITION FILE cqens-20240630_def.xml EX-101.DEF 50548
9 XBRL LABEL FILE cqens-20240630_lab.xml EX-101.LAB 172627
10 XBRL PRESENTATION FILE cqens-20240630_pre.xml EX-101.PRE 127918
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 274695
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 241213699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)